Lakshminarayanan B, Kannappan N, Subburaju T
email@example.com , firstname.lastname@example.org
Lakshminarayanan B1,2, Kannappan N2, Subburaju T1
1Department of Pharmaceutical Chemistry, Ahalia School of Pharmacy, Palakkad - 678557, Kerala, India.
2Department of Pharmacy, Annamalai University, Chidambaram - 608002, Tamilnadu, India.
Volume - 13,
Issue - 4,
Year - 2020
The aim of this study is to evaluate the in vivo antidiabetic and in vitro antioxidant activity of newly synthesized a, ß-unsaturated ketones with ethoxy head. Eleven newly synthesized compounds (E1 - E11) were taken to evaluate for their in vitro antioxidant activity by DPPH and hydrogen peroxide assay method and six compounds which contain electron donating groups were selected for screening of in vivo antidiabetic potential by high fat diet, streptozotocin induced diabetes in Albino Wistar rats. The compounds containing electron donating groups were found to be good antioxidants when compared to standard ascorbic acid. All the selected compounds were found to be effective for antidiabetic activity. Amongst them compound E4 shows more prominent antidiabetic activity when compared to standard metformin.
Cite this article:
Lakshminarayanan B, Kannappan N, Subburaju T. Evaluation of Antidiabetic and Antioxidant potential of some Novel Ethoxylated head of α, β-unsaturated Ketones. Research J. Pharm. and Tech 2020; 13(4): 1955-1960. doi: 10.5958/0974-360X.2020.00352.2
1. Ramesh. B Azma Yasmeen, Shivakumar Swamy and Someswara Rao. B. Synthesis and Anti-inflammatory Activity of Some New 2-Pyrazoline Derivatives. Research J. Pharm. and Tech. 2010; 3(2): 625 - 626.
2. Ishwar Bhat K, Abhishek K. Synthesis and Biological Evaluation of Some Novel Pyrazoline Derivatives Derived from Chalcones. Research J. Pharm. and Tech. 2017; 10(5): 1344-6.
3. Dale S, Maria S, Lisbeth M et al. Transcription factors of lotus: Regulation of isoflavonoid biosynthesis requires coordinated change in transcription factor activity. American Society of Plant Biologists. 2012; 59: 531-47.
4. Xuan F, Juhua F, Zhenhua D et al. Enantioselective synthesis of 2-substituted-1,5-benzodiazepines through domino reaction of o-phenylenediamine and chalcones derivatives. Eur J Chem. 2011; 2011: 5233-6.
5. Saktinathan SP, Vanangamudi G, Thirunarayan G. Synthesis, spectral studies and antimicrobial activities of some 2-naphthyl pyrazoline derivatives. Spectrochimica Acta part A: Mol Biomol Spectrosc. 2012; 95: 693-700.
6. Sashidhara KV, Kumar M, Kumar A. A novel route to synthesis of flavones from salicylaldehyde and acetophenone derivatives. Tetrahedron Lett. 2012; 53: 2355-9.
7. Pankaj Kumar, Abhishek Kumar, Jean Sandra pinto et al. Synthesis and Biological Evaluation of Pyrimidine Derivatives via Pyrrolyl Chalcones. Research J. Pharm. and Tech. 2017; 10(5): 1392-4.
8. Della G, Thomas P, Fakhrya A et al. Cholinesterase inhibitory activities of selected halogenated thiophene chalcones. Cent Nerv Syst Agents Med Chem. 2019; 19: 1-5.
9. Panigrahi N, Ganguly S, Panda J. Ultrasound assisted synthesis, characterization and antimicrobial evaluation of novel oxazolidinone- biphenyl chalcone hybrid derivatives. Indian J Pharm Educ Res. 2019; 53(2): 286-300.
10. Mathew B, Mathew GE, Ucar G et al. Monoamine oxidase inhibitory activity of methoxy-substituted chalcones. Int J Biol Macromol. 2017; 104: 1321-9.
11. Lokesh BVS, Rajendra Prasad Y, Basha Shaik A. Synthesis and biological activity of novel 2,5-dichloro-3-acetylthiophene chalcone derivatives. Indian J Pharm Educ Res. 2017; 51(4s): s679-s690.
12. Mathew B, Abitha H, Suresh J et al. Monoamine oxidase inhibitory action of chalcones: A mini review. Cent Nerv Sys Agent. 2016; 16(2): 120-36.
13. Wang L, Chen G, Lu X et al. Novel chalcones derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: Synthesis, anti-invasive and anti-angiogenic properties. Eur J Med Chem. 2015; 89: 88-97.
14. Abdellatif KR, Elshemy HA, Salama SA, Omar HA. Synthesis, characterization and biological evaluation of novel 4'-fluoro-2'-hydroxy-chalchone derivatives as antioxidant, anti-inflammatory and analgesic agents. J Enzyme Inhib Med Chem. 2014; 8: 1-8.
15. Singh P, Anand A, Kumar V. Recent developments in biological activities of chalcones: A mini review. Eur J Med Chem. 2014; 85: 758-77.
16. Lahsasni SA, Al Korbi FH, Aljaber NA. Synthesis, characterization and evaluation of antioxidant activities of some novel chalcones analogues. Chem Cent J. 2014; 8: 32.
17. Abraham GR, Aguilar HM, Romero NC et al. Synthesis and anti-inflammatory activity of three nitro chalcones. Bioorg Med Chem Lett. 2013; 23: 5519-22.
18. Lakshminarayanan B, Rajamanickam V, Subburaju T, Pradeep Rajkumar LA. Synthesis and antimicrobial activity of some 3-(5-Phenyl-4,5-dihydro-1-substituted pyrazol-3-yl) chromen-2-one. E-Journal of Chemistry. 2010; 7(2): 383-90.
19. Lunkad AS, Kothawade SN, Jadhav DV et al. Synthesis and Antimicrobial Activity of Some New Chalcones Containing Benzofuran and Benzofuran Schiff Bases. Research J. Pharm. and Tech. 2015; 8(3): 276-9.
20. Jennifer Fernandes, Abhishek Kumar and Pankaj Kumar. Synthesis and Biological Activity of Some Novel Quinolinyl Chalcones Derived from N-Substituted 2-Quinolones. Research J. Pharm. and Tech. 2013; 6(12): 1336-9.
21. Tiwari AK. Imbalance in antioxidant defence and human diseases: Multiple approach of natural antioxidants therapy. Current Science (India). 2001; 81(9): 1179-87.
22. Suzen S. Antioxidant activities of synthetic indole derivatives and possible activity mechanisms. Top Heterocycl Chem. 2007; 11: 145-78.
23. Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress - A concise Review. Saudi Pharm J. 2016; 24: 547-53.
24. Lebovitz HE. Oral antidiabetic agents. In: Kahn, CR, Weir, GC (Eds.) Joslin's Diabetes Mellitus. 1994; 13(29): 508-24.
25. Wolff SP. Diabetes mellitus and free radicals. Br Med Bull. 1993; 49: 642-52.
26. Anto RJ, Sukumaran K, Kuttan G et al. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer lett. 1995; 97(1): 33-7.
27. Sharma A, Bharadwaj S, Maan SA et al. Screening of antioxidant activity: An overview. Pharmacogn Rev. 2007; 1: 232-8.
28. Hsieh CT, Hsieh TJ, El Shazly M et al. Synthesis of chalcone derivatives as potential antidiabetic agents. Bioorg Med Chem Lett. 2012; 22(12): 3912-5.
29. Satyanarayana M, Tiwari P, Tripathi BK et al. Synthesis and antihyperglycaemic activity of chalcone based aryloxypropanolamines. Bioorg Med Chem. 2004; 12: 883- 9.
30. Verma AK, Himanshu S, Satyanarayana M et al. Flavone based novel antidiabetic and antidyslipidaemic agents. J Med Chem. 2012; 55: 4551-7.
31. Mahapatra DK, Vivek A, Sanjay KB. Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives. Eur J Med Chem. 2015; 92: 839-65.
32. Shab MA Ayub, Garg SK, Garg KM. Sub-acute toxicity studies on pendimethalin in rats. Indian J Pharmacol. 1997; 29(5): 322-4.
33. Burger C, Fischer DR, Cordenunzzi DA et al. Acute and sub-acute toxicity of the hydroalcoholic extract from Wedelia paludosa (Acmela brasilinsis) (Aastraceae) in mice. J Pharm Pharm Sci. 2005; 8(2): 370-3.
34. Akhila JS, Shyamajith, Deepa, Alwar MC. Acute toxicity studies and determination of median lethal dose. Curr Sci. 2007; 93: 917-20.
35. Lakshminarayanan B, Seung Cheol Baek, Kannappan N et al. Ethoxylated head of chalcones as a new class of multi-targeted MAO inhibitors. ChemistrySelect. 2019; 4: 6614-9.
36. Kaushik N, Kumar N, Kumar A. Synthesis, antioxidant and antidiabetic activity of 1-[(5-subtituted phenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole. Indian J Pharm Sci. 2016; 78(3): 352-9.
37. Kaushik N, Kumar N, Kumar A. Synthesis of substituted 5-phenyl-1-(5-phenyl)-isoxazol-3-yl)-1H-tetrazole as antioxidant agents. J Adv Sci Res. 2015; 6: 14-9.
38. Kaushik N, Kumar N, Kumar A. Synthesis of triazolothiadiazine derivatives as antioxidant agents. Int J Pharm Pharm Sci. 2015; 7: 120-3.
39. Malladi SR, Anisetti R, Rao PR. A facile synthesis, in vitro anti-inflammatory and antioxidant activity of novel benzimidazolylpyrano[2,3-d][1,3]thiazolocarbonitriles. Indian J Pharm Sci. 2014; 76(6): 510-8.
40. Jeyaprakasha GK, Jaganmohan RL, Sakariah KK. Antioxidant activities of flavidin in different in vitro model systems. Bioorg Med Chem. 2004; 12(19): 5141-6.
41. Babu BH, Shylesh BS, Padikkala J. Antioxidant and hepatoprotective effect of Alanthus icicifocus. Fitoterapia. 2001; 72: 272-7.
42. Singh AK, Sing J. Evaluation of anti-diabetic potential of leaves and stem of Flacourtia jangomasin in streptozotocin-induced diabetic rats. Ind J Pharmacol. 2012; 42(5): 301-5.
43. Devi R, Sharma DK. Hypolipidemic effect of different extracts of clerodendron colebrookianum walp in normal and high-fat diet fed rats. J Pharmacol. 2004; 90(1): 63-8.
44. Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev. 1970; 22(4): 485-518.
45. Lenzen S, Panten U. Alloxan: History and mechanism of action. Diabetologia. 1988; 31(6): 337-42.
46. Szkudelski T. The mechanism of alloxan and steptozotocin action in β-cells of the rat pancreas. Physiol Res. 2001; 50(6): 537-46.